Roxithromycin is a semi-synthetic macrolide antibiotic precursor derived from erythromycin. It shares the same 14-membered lactone ring structure as erythromycin, with an oxime-based side chain attached to the macrolide ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Clarithromycin oxime
pharmaceutical intermediate
PUBCHEM_71314812
pharmaceutical research compound
Roxithromycin
pharmaceutical raw material
Zileuton
pharmaceutical raw material
Ponatinib hydrochloride
pharmaceutical raw material
Amlodipine besylate
pharmaceutical raw material
Metformin hydrochloride
pharmaceutical raw material
Erythromycin oxime
pharmaceutical raw material
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
KYTWXIARANQMCA-ZTILBQITSA-N
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/O)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.